Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × irinotecan sucrosofate × Clear all

NCT03712397 2023-04-11

Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy

Phase 2 Completed

Head and Neck Neoplasms